Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › VIJAYA

VIJAYA

Vijaya Diagnostic Centre Limited
Small-capPharma ↗

What the six lenses say about VIJAYA — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹1377.8
2026-07-10
VWAP · 1Y anchor
₹1122
+22.8% from VWAP
P/E · TTM
81.9×
TTM EPS ₹16.8
52-week range
96%
position low→high
RSI(14)
58
momentum

Own sector index

Pharma ↗
Overweight

1M

+6.2%

3M

+15.8%

1Y

+16.2%

Breadth >EMA21

72%

How VIJAYA’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
5.0
avg conviction decile
Leadership
0/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD890›

The actual numbers

Price vs VWAP (1y)+22.8%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+23.8%
Price vs 50-EMA+8.3%
RSI(14)58
RS vs Nifty 500 · 3M+37.0%
RS vs sector · 3M+24.6%
52-week range96%
Volume vs 30d avg0.55×
Volume vs 60d avg0.57×
ATR(14) · volatility60.5
Bollinger width · vol contraction0.101
FundamentalD1081›

The actual numbers

Return on equity (ROE)19.7%
Return on capital (ROCE)21.3%
Operating margin32.6%
Net margin21.3%
Revenue growth · YoY+19.5%
EPS growth · YoY+20.5%
Debt / equity0.44×

Full 8-quarter history in the financials table below.

ValuationD10›

The actual numbers

P/E (TTM)81.9×
TTM EPS₹16.8
52-week range96%
CatalystD435›

The actual numbers

Earnings & momentum35
Capital actions19
Governance65

Every filing in the corporate-announcements panel below.

FlowD240›

The actual numbers

Promoter holding52.5%
Delivery · 30d avg44.7%
Up/down-day asymmetry-2.3pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D8 + D2 ) ÷ 2 = 5.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
85
Conviction score 85/100 · avg-decile strength 5.0/10
Conviction score85/100›
TechnicalD8›
FundamentalD10›
ValuationD1›
CatalystD4›
FlowD2›

Policy

Government policy · Pharma

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+3.6pp
-0.6pp
+5.3pp
+40.7pp
+45.4pp
+42.0pp
Nifty 500
Broad-market baseline
+3.2pp
-0.6pp
+4.7pp
+37.0pp
+40.4pp
+38.2pp
Sector
Own-sector index
—
—
+2.3pp
+24.6pp
+26.0pp
+20.3pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

VIJAYA daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
1377.80+51.80

Relative strength

RS vs baseline · rebased to 100

VIJAYA ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
169.80+5.15

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)156183169173188202205219
↳ change QoQ—+17.1%-7.6%+2.4%+8.7%+7.4%+1.5%+6.8%
EBITDA (₹cr)6580726974828696
EBITDA margin41.5%44.0%42.5%39.9%39.4%40.6%41.9%43.8%
PAT (₹cr)3242353539434348
↳ change QoQ—+33.7%-16.2%-0.8%+11.4%+10.3%+0.0%+11.6%
Net margin20.2%23.0%20.9%20.2%20.7%21.3%21.0%21.9%
EPS (₹)3.064.093.423.403.764.214.204.66
D/E————————
YoY growth · Mar '26Revenue +26.6% YoYPAT +37.1% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 9 Jun '26
    MEDIUMgovernance
    Resignation
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 9 Jun '26
    MEDIUMgovernance
    Resignation of Director/KMP/SMP
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 9 Jun '26
    MEDIUMgovernance
    Resignation
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 9 Jun '26
    MEDIUMgovernance
    Resignation of Director/KMP/SMP
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 9 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 2 Jun '26
    MEDIUMgovernance
    Appointment
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 25 May '26
    MEDIUMgovernance
    Change in Director(s)
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 25 May '26
    MEDIUMgovernance
    Appointment
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 25 May '26
    LOWgovernance
    Change in Management
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 25 May '26
    MEDIUMgovernance
    Change in Director(s)
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 25 May '26
    LOWgovernance
    Change in Management
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 25 May '26
    MEDIUMgovernance
    Cessation
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds VIJAYA

Mutual funds holding VIJAYA (10)

FundWeightAUM ₹crGrade
Nippon India Multi Cap Dir Bns0.86%54,585
Nippon India Multi Cap Bns0.86%54,585
Nippon India Multi Cap Gr0.86%54,585
HDFC Small Cap Gr0.74%38,809
Axis Small Cap Fund Reg Gr0.97%27,840
ICICI Pru Flexicap Reg Gr0.87%21,189
Kotak Small Cap Reg Gr3.95%18,691
HSBC Small Cap Fund Reg Gr1.53%16,877
Axis Large & Mid Cap Reg Gr0.58%15,879
Axis Multicap Reg Gr0.56%9,938

ETFs holding VIJAYA (1)

ETFWeightGrade
Mirae Asset Nifty 500 Healthcare ETF0.51%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Pharma